US2020281838A1PendingUtilityA1
Skin whitening peptide agents
Est. expirySep 1, 2034(~8.1 yrs left)· nominal 20-yr term from priority
A61Q 19/02A61K 8/64A61K 8/14A61P 17/00A61K 8/06
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides new peptides useful as skin whitening agents and their uses in cosmetic or therapeutic applications.
Claims
exact text as granted — not AI-modified1 . A method of whitening skin comprising topically applying a peptide selected from the group consisting of a peptide of up to 15 amino acids in length that contains the sequence of SEQ ID NO: 1, and a peptide up to 5 amino acids in length that contains the sequence QVAVK (SEQ ID NO: 16), VAVK (SEQ ID NO: 9), AVK or QVA, or a functional derivative or a physiologically acceptable salt thereof to the skin of a human, as skin whitening cosmetic agent, wherein the functional derivative is selected from the group consisting of a retropeptide, a retro-inverso peptide, a peptidomimetic and a peptide with methylated amide linkages.
2 . The method of claim 1 , wherein the peptide is up to 5 amino acids in length and contains the amino acid sequence QVA.
3 . The method of claim 1 , wherein the peptide is up to 5 amino acids in length and contains the amino acid sequence QVAVK (SEQ ID NO: 16).
4 . The method of claim 1 , wherein the peptide is up to 5 amino acids in length and contains the amino acid sequence VAVK (SEQ ID NO: 9).
5 . The method of claim 1 , wherein the peptide consists of an amino acid sequence selected from the group consisting of the amino acid sequences QVA, VAVK (SEQ ID NO: 9) and QVAVK (SEQ ID NO: 16).
6 . The method of claim 1 , wherein the peptide is up to 5 amino acids in length and contains the amino acid sequence AVK.
7 . The method of claim 1 , wherein the functional derivative is selected from the group consisting of a retro-inverso peptide, a peptidomimetic and a peptide with methylated amide linkages.
8 . A method of treating hyperpigmentation comprising topically applying a peptide selected from the group consisting of a peptide of up to 15 amino acids in length that contains the sequence of SEQ ID NO: 1, and a peptide up to 5 amino acids in length that contains the sequence QVAVK (SEQ ID NO: 16), VAVK (SEQ ID NO: 9), AVK or QVA, or a functional derivative or a physiologically acceptable salt thereof to the skin of a human having hyperpigmentation, wherein the functional derivative is selected from the group consisting of a retropeptide, a retro-inverso peptide, a peptidomimetic and a peptide with methylated amide linkages.
9 . The method of claim 8 , wherein the hyperpigmentation is selected from the group consisting of melasma, actinic lentigo, pigmentary after-effects from acne, pigmentations due photosensitization, post-inflammatory pigmentations due to an abrasion, a burn, a scar, dermatosis and/or contact allergy, meadows dermatitis, pigmentations due to poison ivy, freckles, nevi, congenital giant nevus, Becker nevus or Spitz nevus.
10 . A cosmetic or pharmaceutical composition comprising a skin whitening peptide selected from the group consisting of a peptide of up to 15 amino acids in length that contains the sequence of SEQ ID NO: 1, and a peptide up to 5 amino acids in length that contains the sequence QVAVK (SEQ ID NO: 16), VAVK (SEQ ID NO: 9), AVK or QVA, or a functional derivative or a physiologically acceptable salt thereof, and a physiologically acceptable carrier and/or excipient, wherein the functional derivative is selected from the group consisting of a retropeptide, a retro-inverso peptide, a peptidomimetic and a peptide with methylated amide linkages.
11 . The composition of claim 10 , wherein said composition is adapted for administration by topical route.
12 . The composition of claim 10 , wherein the peptide is contained in liposomes.
13 . The composition of claim 10 , wherein the composition is in the form of an oil-in-water, water-in-oil or water-in-silicon emulsion.
14 . The composition of claim 10 , further comprising one or several additional active substances.
15 . The composition of claim 14 , wherein said additional active substances are selected from other skin whitening agents, organic or inorganic sunscreens, keratolytic and/or exfoliating agents, moisturizers, emollients, astringents, antiseptics, anti-glycation and/or antioxidant agents, polyols, vitamins, retinoic acid, retinaldehyde, retinol, palmitate, propionate, acetate, hyaluronic acid, anti-inflammatory agents, soothing agents, and deoxyribonucleic or ribonucleic acids, and mixtures thereof.Join the waitlist — get patent alerts
Track US2020281838A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.